UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

Cancer, 2020-07, Vol.126 (14), p.3219-3228

2020

Volltextzugriff (PDF)

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.1560-1568

2018

Volltextzugriff (PDF)

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions

Molecular cancer therapeutics, 2018-05, Vol.17 (5), p.885-896

2018

Volltextzugriff (PDF)

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non–Small-Cell Lung Cancer

Clinical lung cancer, 2017-05, Vol.18 (3), p.281-285

2017

Volltextzugriff (PDF)

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results

International journal of clinical oncology, 2015-06, Vol.20 (3), p.518-524

2015

Volltextzugriff (PDF)

EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer

Journal of thoracic oncology, 2009-12, Vol.4 (12), p.1466-1472

2009

Volltextzugriff (PDF)

Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells

Molecular cancer research, 2008-05, Vol.6 (5), p.808-818

2008

Volltextzugriff (PDF)

Phase II study of dovitinib in patients progressing on anti-vascular endothelial growth factor therapy

Cancer treatment and research communications, 2017, Vol.10, p.21-26

2017

Volltextzugriff (PDF)

Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model

Menopause (New York, N.Y.), 2012-01, Vol.19 (1), p.96-103

2012

Volltextzugriff (PDF)

GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines

Leukemia research, 2010-01, Vol.34 (1), p.69-76

2010

Volltextzugriff (PDF)

Bridging Tumor Genomics to Patient Outcomes Through an Integrated Patient-Derived Xenograft Platform

Clinical lung cancer, 2015-05, Vol.16 (3), p.165-172

2015

Volltextzugriff (PDF)

Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen‐dependent and independent prostate cancer cell lines

BJU international, 2008-11, Vol.102 (10), p.1458-1466

2008

Volltextzugriff (PDF)

L-BLP25 Vaccine plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-Expressing Mammary Tumors in Mice

Clinical cancer research, 2012-05, Vol.18 (10), p.2861-2871

2012

Volltextzugriff (PDF)

Abstract 415: A single molecule detection system for comprehensive analysis of cancer related cellular pathways

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.415-415

2018

Volltextzugriff (PDF)

Current treatment options for vulvovaginal atrophy

Expert Review of Obstetrics & Gynecology, 2011-03, Vol.6 (2), p.141-151

2011

Volltextzugriff (PDF)

Interrogating MEK inhibition in a KRAS-mutant lung cancer patient-derived xenograft (PDX) resource

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20561-e20561

2016

Volltextzugriff (PDF)

Phase II study of dovitinib in patients (Pts) progressing on anti-vascular endothelial growth factor (VEGF) therapy

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.616-616

2016

Volltextzugriff (PDF)

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-07, Vol.13 (10), p.1560-1568

2018

Volltextzugriff (PDF)

Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8025-8025

2014

Volltextzugriff (PDF)

The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22151-e22151

2014

Volltextzugriff (PDF)

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms

The Prostate, 2007-04, Vol.67 (5), p.521-535

2007

Volltextzugriff (PDF)

Two bipartite NLSs mediate constitutive nuclear localization of Mcm10

Current genetics, 2003-12, Vol.44 (4), p.195-201

2003

Volltextzugriff (PDF)

IMPAIRMENT OF THE DNA REPAIR AND GROWTH ARREST PATHWAYS BY p53R2 SILENCING ENHANCES DNA DAMAGE- INDUCED APOPTOSIS IN A p53-DEPENDENT MANNER IN PROSTATE CANCER CELLS

The Journal of urology, 2008, Vol.179 (4), p.424-424

2008

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non–Small-Cell Lung Cancer

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results

EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer

Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells

Phase II study of dovitinib in patients progressing on anti-vascular endothelial growth factor therapy

Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model

GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines

Bridging Tumor Genomics to Patient Outcomes Through an Integrated Patient-Derived Xenograft Platform

Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen‐dependent and independent prostate cancer cell lines

L-BLP25 Vaccine plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-Expressing Mammary Tumors in Mice

Abstract 415: A single molecule detection system for comprehensive analysis of cancer related cellular pathways

Current treatment options for vulvovaginal atrophy

Interrogating MEK inhibition in a KRAS-mutant lung cancer patient-derived xenograft (PDX) resource

Phase II study of dovitinib in patients (Pts) progressing on anti-vascular endothelial growth factor (VEGF) therapy

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer

Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource

The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms

Two bipartite NLSs mediate constitutive nuclear localization of Mcm10

IMPAIRMENT OF THE DNA REPAIR AND GROWTH ARREST PATHWAYS BY p53R2 SILENCING ENHANCES DNA DAMAGE- INDUCED APOPTOSIS IN A p53-DEPENDENT MANNER IN PROSTATE CANCER CELLS

Suchergebnisse filtern